About Non-spherocytic hemolytic anemia due to hexokinase deficiency
Non-spherocytic hemolytic anemia due to hexokinase deficiency is a rare disease catalogued by Orphanet (ORPHA:90031). It is associated with the HK1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Non-spherocytic hemolytic anemia due to hexokinase deficiency trials.
Search ClinicalTrials.gov for "Non-spherocytic hemolytic anemia due to hexokinase deficiency" or filter by Orphanet code ORPHA:90031 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Non-spherocytic hemolytic anemia due to hexokinase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Non-spherocytic hemolytic anemia due to hexokinase deficiency. Updated daily.